Lee Noel Clark

Lee Noel Clark possesses extensive experience in clinical science and research leadership across various biotechnology and pharmaceutical firms. As a Senior Clinical Science Director at Exelixis, responsibilities included leading the Phase 3 study of cabozantinib. Prior roles include Clinical Scientist/Medical Writer at Abbott, where contributions were made to FDA submissions and scientific publications regarding coronary artery stents. Additionally, leadership positions at Pfizer focus on early oncology project strategies, while prior engagements at Five Prime Therapeutics and Zogenix involved managing clinical development programs and regulatory strategies. Lee Noel Clark holds a PhD in Molecular and Cellular Biology from the University of California, Berkeley, and a Bachelor of Applied Science in Biology from the University of Virginia.